Xia X - Search Results

1

Pharmacokinetic-pharmacodynamic integration and resistance of tiamulin against Mycoplasma hyopneumoniae in an in vitro dynamic model.

Huang Z, Xia X, Mao C, Gu X, Shen X, Yang H, Ding H. Huang Z, et al. Among authors: xia x. Microb Pathog. 2020 Oct;147:104255. doi: 10.1016/j.micpath.2020.104255. Epub 2020 May 12. Microb Pathog. 2020. PMID: 32407861 Free article.

2

Pharmacokinetic and Pharmacodynamic Integration and Resistance Analysis of Tilmicosin Against Mycoplasma gallisepticum in an In Vitro Dynamic Model.

Huang Z, Wu Y, Zhou Z, Xia X, Gu X, Cai Q, Shen X, Yang H, Ding H. Huang Z, et al. Among authors: xia x. Front Pharmacol. 2019 Jun 12;10:670. doi: 10.3389/fphar.2019.00670. eCollection 2019. Front Pharmacol. 2019. PMID: 31293418 Free PMC article.

3

The PK/PD Integration and Resistance of Tilmicosin against Mycoplasma hyopneumoniae.

Huang Z, Hu Z, Zheng H, Xia X, Gu X, Shen X, Yang H, Ding H. Huang Z, et al. Among authors: xia x. Pathogens. 2020 Jun 19;9(6):487. doi: 10.3390/pathogens9060487. Pathogens. 2020. PMID: 32575357 Free PMC article.

4

Emergence and Mechanism of Resistance of Tulathromycin Against Mycoplasma hyopneumoniae in a PK/PD Model and the Fitness Costs of 23S rRNA Mutants.

Xia X, Yang L, Ling Y, Yu J, Ding H. Xia X, et al. Front Vet Sci. 2022 Feb 11;9:801800. doi: 10.3389/fvets.2022.801800. eCollection 2022. Front Vet Sci. 2022. PMID: 35224081 Free PMC article.

5

Pharmacokinetic/pharmacodynamic integration of amphenmulin: a novel pleuromutilin derivative against Mycoplasma gallisepticum.

Wang W, Yu J, Ji X, Xia X, Ding H. Wang W, et al. Among authors: xia x. Microbiol Spectr. 2024 Feb 6;12(2):e0367523. doi: 10.1128/spectrum.03675-23. Epub 2023 Dec 19. Microbiol Spectr. 2024. PMID: 38112481 Free PMC article.

6

The novel pleuromutilin derivative 22-((4-((4-nitrophenyl)acetamido)phenyl)thio)deoxy pleuromutilin possesses robust anti-mycoplasma activity both in vitro and in vivo.

Xia X, Ji X, Li Y, Wang Y, Zhao Y, Wang W, Ding H. Xia X, et al. Front Pharmacol. 2024 Dec 20;15:1491223. doi: 10.3389/fphar.2024.1491223. eCollection 2024. Front Pharmacol. 2024. PMID: 39759447 Free PMC article.

7

Triethylamine-mediated protonation-deprotonation unlocks dual-drug self assembly to suppress breast cancer progression and metastasis.

Lei L, Song Y, Yang L, Wang Y, Xia X, Zhang Y, Zhang X, Zhang X, Duggal I, He B, Peppas NA, Cao J, Gao H. Lei L, et al. Among authors: xia x. Proc Natl Acad Sci U S A. 2025 Feb 4;122(5):e2416796122. doi: 10.1073/pnas.2416796122. Epub 2025 Jan 28. Proc Natl Acad Sci U S A. 2025. PMID: 39874295

8

BET inhibition induces GDH1-dependent glutamine metabolic remodeling and vulnerability in liver cancer.

Mi W, You J, Li L, Zhu L, Xia X, Yang L, Li F, Xu Y, Bi J, Liu P, Chen L, Li F. Mi W, et al. Among authors: xia x. Life Metab. 2024 Apr 26;3(4):loae016. doi: 10.1093/lifemeta/loae016. eCollection 2024 Aug. Life Metab. 2024. PMID: 39872506 Free PMC article.

9

Tuning mitochondrial dynamics for aging intervention.

Yao X, Xia X, Hay DC, Shipston M, Ouyang H. Yao X, et al. Among authors: xia x. Life Med. 2024 Feb 8;3(1):lnae008. doi: 10.1093/lifemedi/lnae008. eCollection 2024 Feb. Life Med. 2024. PMID: 39872392 Free PMC article. No abstract available.

10

Piezo-Capacitive Flexible Pressure Sensor with Magnetically Self-Assembled Microneedle Array.

Li S, Wang Y, Wu Y, Asghar W, Xia X, Liu C, Bai X, Shang J, Liu Y, Li RW. Li S, et al. Among authors: xia x. ACS Sens. 2025 Jan 27. doi: 10.1021/acssensors.4c02895. Online ahead of print. ACS Sens. 2025. PMID: 39869113

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,132 results

Search Page

Filters